FNDX announces another promo contract & conference FendX Technologies (FNDX.c) is continuing to gain traction up almost 10% right now and over 70% since its late March IPO, announcing another promo contract today alongside their participation in the Bloom Burton & Co Healthcare Investor Conference.
The conference, held on April 25, 2023, hosts Canada's premier publicly traded and venture-backed private companies and will attended by FNDX President & CEO Dr. Myers.
This news follows FNDX's engagement of Dunmore for the scale-up development of RepelWrap, a first-of-its-kind coating product with patent-pending and proprietary technology with unique repelling properties that prevent the adhesion of pathogens, bacteria and viruses, reducing their transmission on surfaces prone to contamination.
FNDX's engagement of Dunmore is an important milestone as it's the first step to assessing and creating an automated manufacturing process, positioning FNDX for significant revenue generation once in commercial production which is expected in 2024.
News Releases:
https://www.newsfilecorp.com/release/162167
https://www.newsfilecorp.com/release/162106
Deep dive DD packet: https://www.reddit.com/r/PennyStocksCanada/comments/11qhnvo/fendx_technologies_due_diligence_packet_a/
Posted on behalf of FendX Technologies Inc.